ArticleAIDS and behavior2026
Use of Tobacco and Alternative Nicotine Products Among People with HIV: A Cross-Sectional Multicenter Survey.
Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Observational
- Extreme Cardiovascular Risk and LDL-C Target Achievement in People With HIV.Open forum infectious diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
People with HIV (PWH) have a higher prevalence of smoking compared to the general population, which contributes to an increased risk of non-AIDS-related comorbidities. Heated tobacco products (HTPs) and electronic cigarettes (e-cigarettes) have added complexity to tobacco use behaviors. This study aimed to investigate smoking habits, including HTPs and e-cigarettes use and to describe patterns of tobacco use. We conducted a cross-sectional survey among PWH attending five Italian University Hospitals. An anonymous questionnaire collected information on smoking status, history, use of HTPs and e-cigarettes, motivations for product use, and engagement with smoking cessation services and lung health screenings. A total of 1,081 PWH were included: 41.9% were current smokers (CS), 31.5% former smokers (FS), and 26.6% never smokers. CS reported a median consumption of 15 cigarettes per day and a smoking duration of 30 years. HTP use was reported by 10.6% of participants, most commonly among FS and CS, while e-cigarette use was reported by 15.9%, with the highest prevalence among younger individuals. Dual use of cigarettes and e-cigarettes was found in 21.0% of CS. The main reasons for e-cigarette use were smoking reduction (75%) and perceived lower harm (53.5%). Only 5% of participants accessed smoking cessation services, and 60.5% of CS had attempted to quit, but physician recommendations for cessation support were infrequent (21.0%). Lung health screening was underutilized, with only 17.0% undergoing a CT scan and 12.7% a pulmonology consultation. These findings underscore the need for targeted strategies to address tobacco use and improve preventive care in PWH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.